Large pharmaceutical firms eye M&As as growth engines

Large domestic pharmaceutical companies are eyeing mergers and acquisitions (M&As) with small- and medium-sized firms as part of efforts to find new growth engines in the rapidly changing business environment.

The M&As market in the local pharmaceutical and wholesaling sector is expected to heat up this year as major pharmaceutical firms are hungry for growth.

"The country is likely to se...